First Time Loading...

Arcus Biosciences Inc
NYSE:RCUS

Watchlist Manager
Arcus Biosciences Inc Logo
Arcus Biosciences Inc
NYSE:RCUS
Watchlist
Price: 15.33 USD -1.1%
Updated: Jun 10, 2024

Arcus Biosciences Inc
PP&E Net

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Arcus Biosciences Inc
PP&E Net Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive PP&E Net Analysis
Latest Figures & CAGR of Competitors

Company PP&E Net CAGR 3Y CAGR 5Y CAGR 10Y
Arcus Biosciences Inc
NYSE:RCUS
PP&E Net
$51m
CAGR 3-Years
23%
CAGR 5-Years
36%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
PP&E Net
$5B
CAGR 3-Years
-1%
CAGR 5-Years
9%
CAGR 10-Years
8%
Gilead Sciences Inc
NASDAQ:GILD
PP&E Net
$5.3B
CAGR 3-Years
2%
CAGR 5-Years
3%
CAGR 10-Years
15%
Amgen Inc
NASDAQ:AMGN
PP&E Net
$6B
CAGR 3-Years
7%
CAGR 5-Years
2%
CAGR 10-Years
1%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
PP&E Net
$1.5B
CAGR 3-Years
4%
CAGR 5-Years
13%
CAGR 10-Years
7%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
PP&E Net
$4.2B
CAGR 3-Years
9%
CAGR 5-Years
10%
CAGR 10-Years
22%

See Also

What is Arcus Biosciences Inc's PP&E Net?
PP&E Net
51m USD

Based on the financial report for Mar 31, 2024, Arcus Biosciences Inc's PP&E Net amounts to 51m USD.

What is Arcus Biosciences Inc's PP&E Net growth rate?
PP&E Net CAGR 5Y
36%

Over the last year, the PP&E Net growth was 38%. The average annual PP&E Net growth rates for Arcus Biosciences Inc have been 23% over the past three years , 36% over the past five years .